| Patent application number | Description | Published |
|---|
| 20090105746 | GUIDEWIRE STOP - A user-actuatable guidewire stop is disclosed which can be used to stop and/or lock a medical device on a guidewire advanced through a body lumen. In one embodiment, the guidewire stop is configured as a coil spring having an inner lumen configured to slideably and rotationally receive the guidewire in an unlocked configuration, and to frictionally engage the guidewire in a locked configuration, wherein in the inside diameter of the coil spring in the locked configuration is smaller than the diameter in the unlocked configuration. A restraining member maintains the coil spring in the unlocked configuration during deployment and is removed at the interventional site causing the coil spring to collapse onto the guidewire. The guidewire stop can be employed with an embolic filter or another intravascular device. | 04-23-2009 |
| 20090149806 | Embolism Filter with Self-Deployable Guidewire Stop - An embolism filter adapted to selectively stop an embolism filter along a length of guidewire, including a filter adapted to encircle a guidewire and at least one self-deploying stop attached to the filter and which selectively stops movement of said filter. | 06-11-2009 |
| 20090306639 | Cryoprobe incorporating electronic module, and system utilizing same - A cryotherapy system comprises a cryoprobe comprising, for example, either an electronic module including a memory or a response module operable to respond to a query signal with a response signal. A communications interface uses these modules to establish a unique identification of the cryoprobe, and a control module regulates delivery of cryogen to the cryoprobe according to calculations at least partially based on stored data associated with that unique cryoprobe identification. | 12-10-2009 |
| 20100204725 | GUIDEWIRE STOP - A user-actuatable guidewire stop is disclosed which can be used to stop and/or lock a medical device on a guidewire advanced through a body lumen. The guidewire stop is configured as a coil spring having an inner lumen configured to slideably and rotationally receive the guidewire in an unlocked configuration, and to frictionally engage the guidewire in a locked configuration. The coil spring is composed of turns having at least one protrusion disposed on a turn of the coil spring and adapted for engagement with a corresponding recess disposed on an adjacent turn of the coil spring, wherein the at least one protrusion interlocks with the corresponding recess to maintain the coil spring in the unlocked configuration. The coil spring transitions into the unlocked configuration by disengaging the at least one protrusion from the corresponding recess. | 08-12-2010 |
| Patent application number | Description | Published |
|---|
| 20100209403 | ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY - A method of treating ischemia in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the ischemia in the subject. A method of treating a medical condition requiring connective tissue regeneration and/or repair is also disclosed. | 08-19-2010 |
| 20110256108 | METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION - A method of selecting a population of adherent cells of a placenta tissue suitable for transplantation is disclosed. The method comprising: (a) determining prior to transplantation in a candidate population of adherent cells of a placenta tissue at least one of the following parameters: (i) percentage of viable cells in the candidate population; (ii) immune phenotype of cells in the candidate population; (iii) xeno-contamination in the candidate population; (iv) sterility of the candidate population; and (v) immunosuppressive activity of cells in the candidate population; and (b) selecting or excluding the candidate population according to predetermined values of at least one of the parameters, thereby selecting a population of adherent cells of the placenta tissue suitable for transplantation. | 10-20-2011 |
| 20110256159 | ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY - A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta or adipose tissue under 3 dimensional (3D) culturing conditions which allow cell expansion, the conditions comprising perfusion. | 10-20-2011 |
| 20110256160 | ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY - A method of culturing adherent cells from a placenta or adipose tissue is disclosed. The method comprising culturing the adherent cells from the placenta or adipose tissue under 2 dimensional (2D) culturing conditions which allow cell expansion, the conditions comprising continuous passaging of the cells for at least 4 passages. | 10-20-2011 |
